Cargando…
47. Long Term Outcomes of Pulse-taper Corticosteroid Therapy (PCT) for Refractory Non-HIV Cryptococcal Meningoencephalitis
BACKGROUND: Cryptococcal meningoencephalitis (CM) is a major cause of mortality in HIV/AIDS, transplant recipients and previously healthy individuals. In the latter, a post-infectious inflammatory response syndrome (PIIRS) is associated with poor clinical response despite prior amphotericin therapy...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778016/ http://dx.doi.org/10.1093/ofid/ofaa439.357 |
_version_ | 1783631038953553920 |
---|---|
author | Anjum, Seher Williamson, Peter Magone, Teresa Edmond, Fitzgibbon Krieger, Chantal Murphy, Elizabeth Zalewski, Chris King, Kelly Chisholm, Jennifer Brewer, Carmen Nath, Avindra Billioux, Jean Kosa, Peter Bielekova, Bibiana Bennett, John Marr, Kieren Hammoud, Dima Dean, Owen Kim, Jeff |
author_facet | Anjum, Seher Williamson, Peter Magone, Teresa Edmond, Fitzgibbon Krieger, Chantal Murphy, Elizabeth Zalewski, Chris King, Kelly Chisholm, Jennifer Brewer, Carmen Nath, Avindra Billioux, Jean Kosa, Peter Bielekova, Bibiana Bennett, John Marr, Kieren Hammoud, Dima Dean, Owen Kim, Jeff |
author_sort | Anjum, Seher |
collection | PubMed |
description | BACKGROUND: Cryptococcal meningoencephalitis (CM) is a major cause of mortality in HIV/AIDS, transplant recipients and previously healthy individuals. In the latter, a post-infectious inflammatory response syndrome (PIIRS) is associated with poor clinical response despite prior amphotericin therapy and CSF culture conversion. Data on effective treatment is limited. METHODS: Between March 2015 and March 2020, 15 patients with CM/PIIRS were treated with adjunctive pulse – taper corticosteroid therapy (PCT) consisting of intravenous methylprednisolone 1 gm daily for 1 week followed by oral prednisone 1 mg/kg/d, tapered based on clinical and radiological response plus oral fluconazole. Montreal cognitive assessments (MOCA), Karnofsky Performance scores, MRI brain scans, eye and audiologic exams were conducted at baseline and after pulse completion. CSF parameters were assessed prior to and after the pulse. RESULTS: 80% of patients were male, median age 51 years. Median time from antifungal treatment to steroid initiation was 6 weeks. The most common symptoms at PIIRS diagnosis were progressive deterioration in mental status and vision changes. There was a significant improvement in MOCA(n=14) and Karnofsky(n=15) scores at 3 weeks (p< 0.0003), which was accompanied by improvements in CSF: serum, glucose ratios, CSF WBC, protein and activated CD4 T cells (n=14) post-pulse (p< 0.003). Additionally, soluble CSF IL-6 and sCD25 levels improved (p = 0.03). Neurofilament light chain levels (NFL), a biomarker of axonal damage, showed significant reductions over a 30-month period (Generalized Estimating Equation coefficient = 0.128) and a negative correlation with post pulse MOCA scores (r = - 0.8; p = 0.01). Papilledema (n=8) and visual field deficits (n=11) improved significantly (p< 0.0005) after 2 months of pulse completion. Brain MRI showed improvement of radiological findings in 11 patients (p=0.001). Five out of 7 patients who underwent audiological testing demonstrated hearing improvement after 3 weeks post-pulse. CSF cultures remained negative. [Image: see text] CONCLUSION: PCT in this small cohort of PIIRS patients was associated with persistent improvements in CM-related complications with minimal toxicity and no recurrence of infection. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-7778016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77780162021-01-07 47. Long Term Outcomes of Pulse-taper Corticosteroid Therapy (PCT) for Refractory Non-HIV Cryptococcal Meningoencephalitis Anjum, Seher Williamson, Peter Magone, Teresa Edmond, Fitzgibbon Krieger, Chantal Murphy, Elizabeth Zalewski, Chris King, Kelly Chisholm, Jennifer Brewer, Carmen Nath, Avindra Billioux, Jean Kosa, Peter Bielekova, Bibiana Bennett, John Marr, Kieren Hammoud, Dima Dean, Owen Kim, Jeff Open Forum Infect Dis Poster Abstracts BACKGROUND: Cryptococcal meningoencephalitis (CM) is a major cause of mortality in HIV/AIDS, transplant recipients and previously healthy individuals. In the latter, a post-infectious inflammatory response syndrome (PIIRS) is associated with poor clinical response despite prior amphotericin therapy and CSF culture conversion. Data on effective treatment is limited. METHODS: Between March 2015 and March 2020, 15 patients with CM/PIIRS were treated with adjunctive pulse – taper corticosteroid therapy (PCT) consisting of intravenous methylprednisolone 1 gm daily for 1 week followed by oral prednisone 1 mg/kg/d, tapered based on clinical and radiological response plus oral fluconazole. Montreal cognitive assessments (MOCA), Karnofsky Performance scores, MRI brain scans, eye and audiologic exams were conducted at baseline and after pulse completion. CSF parameters were assessed prior to and after the pulse. RESULTS: 80% of patients were male, median age 51 years. Median time from antifungal treatment to steroid initiation was 6 weeks. The most common symptoms at PIIRS diagnosis were progressive deterioration in mental status and vision changes. There was a significant improvement in MOCA(n=14) and Karnofsky(n=15) scores at 3 weeks (p< 0.0003), which was accompanied by improvements in CSF: serum, glucose ratios, CSF WBC, protein and activated CD4 T cells (n=14) post-pulse (p< 0.003). Additionally, soluble CSF IL-6 and sCD25 levels improved (p = 0.03). Neurofilament light chain levels (NFL), a biomarker of axonal damage, showed significant reductions over a 30-month period (Generalized Estimating Equation coefficient = 0.128) and a negative correlation with post pulse MOCA scores (r = - 0.8; p = 0.01). Papilledema (n=8) and visual field deficits (n=11) improved significantly (p< 0.0005) after 2 months of pulse completion. Brain MRI showed improvement of radiological findings in 11 patients (p=0.001). Five out of 7 patients who underwent audiological testing demonstrated hearing improvement after 3 weeks post-pulse. CSF cultures remained negative. [Image: see text] CONCLUSION: PCT in this small cohort of PIIRS patients was associated with persistent improvements in CM-related complications with minimal toxicity and no recurrence of infection. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7778016/ http://dx.doi.org/10.1093/ofid/ofaa439.357 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Abstracts Anjum, Seher Williamson, Peter Magone, Teresa Edmond, Fitzgibbon Krieger, Chantal Murphy, Elizabeth Zalewski, Chris King, Kelly Chisholm, Jennifer Brewer, Carmen Nath, Avindra Billioux, Jean Kosa, Peter Bielekova, Bibiana Bennett, John Marr, Kieren Hammoud, Dima Dean, Owen Kim, Jeff 47. Long Term Outcomes of Pulse-taper Corticosteroid Therapy (PCT) for Refractory Non-HIV Cryptococcal Meningoencephalitis |
title | 47. Long Term Outcomes of Pulse-taper Corticosteroid Therapy (PCT) for Refractory Non-HIV Cryptococcal Meningoencephalitis |
title_full | 47. Long Term Outcomes of Pulse-taper Corticosteroid Therapy (PCT) for Refractory Non-HIV Cryptococcal Meningoencephalitis |
title_fullStr | 47. Long Term Outcomes of Pulse-taper Corticosteroid Therapy (PCT) for Refractory Non-HIV Cryptococcal Meningoencephalitis |
title_full_unstemmed | 47. Long Term Outcomes of Pulse-taper Corticosteroid Therapy (PCT) for Refractory Non-HIV Cryptococcal Meningoencephalitis |
title_short | 47. Long Term Outcomes of Pulse-taper Corticosteroid Therapy (PCT) for Refractory Non-HIV Cryptococcal Meningoencephalitis |
title_sort | 47. long term outcomes of pulse-taper corticosteroid therapy (pct) for refractory non-hiv cryptococcal meningoencephalitis |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778016/ http://dx.doi.org/10.1093/ofid/ofaa439.357 |
work_keys_str_mv | AT anjumseher 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT williamsonpeter 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT magoneteresa 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT edmondfitzgibbon 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT kriegerchantal 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT murphyelizabeth 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT zalewskichris 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT kingkelly 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT chisholmjennifer 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT brewercarmen 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT nathavindra 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT billiouxjean 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT kosapeter 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT bielekovabibiana 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT bennettjohn 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT marrkieren 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT hammouddima 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT deanowen 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis AT kimjeff 47longtermoutcomesofpulsetapercorticosteroidtherapypctforrefractorynonhivcryptococcalmeningoencephalitis |